SHANGHAI PHARMACEUTICALS HOLDING CO financial statements, including revenue, expenses, profit, and loss

The total revenue of 2607 for the last quarter is 76.19 B HKD, and it's 2.19% higher compared to the previous quarter. The net income of Q3 24 is 1.21 B HKD.